Category Archives: People

IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx™ DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma

First peer-reviewed publication of chemotherapy-resistant gamma-delta T cells (DeltEx Drug Resistant Immunotherapy or DRI) clinical results in newly diagnosed glioblastoma Repeat-dose patients achieved median progression-free survival (mPFS) of 16.1 months, more than double the ~6.9-month standard of care benchmark, with no dose-limiting toxicities (DLTs) NEW YORK, July 09, 2026 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: […]

Vera Therapeutics Announces Appointment of Nancy Boman as Chief Regulatory Officer and Planned Retirement of William Turner

BRISBANE, Calif., July 09, 2026 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA), a commercial-stage biotechnology company, today announced a planned transition of the Chief Regulatory Officer position. William Turner, current Chief Regulatory Officer of Vera Therapeutics, is planning to retire and transition to the role of Strategic Advisor in the third quarter of this […]

VisCardia Implants First U.S. Patient in RECOVER-HF Pivotal Trial

Milestone in pivotal IDE evaluation of VisONE™ Synchronized Diaphragmatic Stimulation Therapy for symptomatic heart failure with reduced ejection fraction; FDA Breakthrough Device Designation PORTLAND, Ore., July 09, 2026 (GLOBE NEWSWIRE) — VisCardia, Inc. today announced the first U.S. patient has been implanted in its RECOVER-HF pivotal trial of VisONE™ Synchronized Diaphragmatic Stimulation (SDS) Therapy, also […]

Sam’s Club® and Weight Watchers® Collaborate to Expand Access to Affordable, Holistic Wellness Experiences for Members

Sam’s Club Plus members may receive a complimentary three-month Weight Watchers Core membership, while all Sam’s Club members can save up to 50% on select Weight Watchers programs Collaboration connects medication support, nutrition, healthy food choices and trusted pharmacy care in one seamless experience Brings together two trusted membership brands at a time of growing […]

Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026

PHILADELPHIA, July 09, 2026 (GLOBE NEWSWIRE) — Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases, including type 1 diabetes (T1D), and cancer, today announced that its abstracts have been accepted for oral presentations at two upcoming scientific congresses: 62nd Annual Meeting of the […]

LGI Homes Unveils The Meadows at Riverside with Grand Opening Event in Falling Waters, West Virginia

FALLING WATERS, W.Va., July 08, 2026 (GLOBE NEWSWIRE) — LGI Homes proudly announces the grand opening of The Meadows at Riverside, an exciting new single-family home community located in Falling Waters. This highly anticipated neighborhood offers thoughtfully designed homes featuring modern upgrades, spacious layouts and exceptional value in a scenic riverside setting. The Meadows at […]

Outliyr’s Independent Spectrometer Tests Find Popular Red Light Therapy Devices Delivering From 67 Percent to Nearly Triple Their Advertised Power

Outliyr’s free public database catalogs more than seventy red light therapy panels and other light therapy devices, and publishes its own spectrometer measurements next to manufacturer claims for the units it has tested hands-on, seven so far. Austin, TX, July 08, 2026 (GLOBE NEWSWIRE) — Two light therapy devices tested on a calibrated spectrometer at […]

Rhythm Pharmaceuticals Announces The New England Journal of Medicine Publication of Phase 3 TRANSCEND Trial Results in Acquired Hypothalamic Obesity

BOSTON, July 08, 2026 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that results from its pivotal Phase 3 TRANSCEND trial evaluating setmelanotide, a melanocortin-4 receptor (MC4R) agonist, in patients with acquired hypothalamic obesity have been […]

Range Impact Announces Vin Ferrara, MD, MBA, Has Joined the Company as Vice President, Real Estate

CLEVELAND, OHIO, July 08, 2026 (GLOBE NEWSWIRE) — Range Impact, Inc. (OTC: RNGE) (“Range Impact” or the “Company”), a public company dedicated to acquiring, reclaiming and repurposing former industrial and mine properties throughout Appalachia, today announced the appointment of Vin Ferrara, MD, MBA, as Vice President, Real Estate. Mr. Ferrara is the Founder and Managing […]

UPDATE: Endogenex Announces Full Enrollment of the ReCET Clinical Study

350 Patients Enrolled Across Sites in the United States and Australia, Advancing the Path to FDA Approval of a Novel Endoscopic Treatment for Type 2 Diabetes MINNEAPOLIS, July 08, 2026 (GLOBE NEWSWIRE) — Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes (T2D), announced that the ReCET Clinical […]